TD Asset Management
RVMDW icon

TD Asset Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

TD Asset Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Hold
40,636
– – ﹤0.01% 1191
2026
Q1 		$70.7K Hold
40,636
– – ﹤0.01% 1228
2025
Q4 		$38.2K Hold
40,636
– – ﹤0.01% 1230
2025
Q3 		$12.2K Hold
40,636
– – ﹤0.01% 1233
2025
Q2 		$11K Hold
40,636
– – ﹤0.01% 1191
2025
Q1 		$1.54K Hold
40,636
– – ﹤0.01% 1215
2024
Q4 		$6.57K Hold
40,636
– – ﹤0.01% 1240
2024
Q3 		$5.53K Hold
40,636
– – ﹤0.01% 1380
2024
Q2 		$2.9K Hold
40,636
– – ﹤0.01% 1358
2024
Q1 		$6.5K Hold
40,636
– – ﹤0.01% 1377
2023
Q4 		$13.4K Buy
+40,636
New +$18.2K ﹤0.01% 1380

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

TD Asset Management's RVMDW Position: Q2 2026 in Review

TD Asset Management held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 40,636 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

TD Asset Management first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • TD Asset Management held 40,636 shares of Revolution Medicines Inc Warrant worth $382K as of Q2 2026.
  • TD Asset Management left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1191 holding.
  • TD Asset Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.